{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer", "Commiphora wightii", "Z and E isomers", "anticancer activities", "guggulsterone"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "36046484", "DateRevised": {"Year": "2022", "Month": "09", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.37349/etat.2020.00019"], "Journal": {"ISSN": "2692-3114", "JournalIssue": {"Volume": "1", "Issue": "5", "PubDate": {"Year": "2020"}}, "Title": "Exploration of targeted anti-tumor therapy", "ISOAbbreviation": "Explor Target Antitumor Ther"}, "ArticleTitle": "Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer.", "Pagination": {"StartPage": "313", "EndPage": "342", "MedlinePgn": "313-342"}, "Abstract": {"AbstractText": ["Cancer is one of the most dreadful diseases in the world with a mortality of 9.6 million annually. Despite the advances in diagnosis and treatment during the last couple of decades, it still remains a serious concern due to the limitations associated with currently available cancer management strategies. Therefore, alternative strategies are highly required to overcome these glitches. The importance of medicinal plants as primary healthcare has been well-known from time immemorial against various human diseases, including cancer. <i>Commiphora wightii</i> that belongs to Burseraceae family is one such plant which has been used to cure various ailments in traditional systems of medicine. This plant has diverse pharmacological properties such as antioxidant, antibacterial, antimutagenic, and antitumor which mostly owes to the presence of its active compound guggulsterone (GS) that exists in the form of Z- and E-isomers. Mounting evidence suggests that this compound has promising anticancer activities and was shown to suppress several cancer signaling pathways such as NF-\u03baB/ERK/MAPK/AKT/STAT and modulate the expression of numerous signaling molecules such as the farnesoid X receptor, cyclin D1, survivin, caspases, HIF-1\u03b1, MMP-9, EMT proteins, tumor suppressor proteins, angiogenic proteins, and apoptotic proteins. The current review is an attempt to summarize the biological activities and diverse anticancer activities (both <i>in vitro</i> and <i>in vivo</i>) of the compound GS and its derivatives, along with its associated mechanism against various cancers."], "CopyrightInformation": "\u00a9 The Author(s) 2020."}, "AuthorList": [{"Identifier": ["0000-0003-0261-5538"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India."}], "LastName": "Girisa", "ForeName": "Sosmitha", "Initials": "S"}, {"Identifier": ["0000-0003-3529-7062"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India."}], "LastName": "Parama", "ForeName": "Dey", "Initials": "D"}, {"Identifier": ["0000-0001-7854-2406"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India."}], "LastName": "Harsha", "ForeName": "Choudhary", "Initials": "C"}, {"Identifier": ["0000-0003-2497-8313"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India."}], "LastName": "Banik", "ForeName": "Kishore", "Initials": "K"}, {"Identifier": ["0000-0001-9121-6816"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India."}], "LastName": "Kunnumakkara", "ForeName": "Ajaikumar B", "Initials": "AB"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Explor Target Antitumor Ther", "NlmUniqueID": "101770662", "ISSNLinking": "2692-3114"}, "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. J Cancer Res Pract. 2017;4:127\u20139. 10.1016/j.jcrpr.2017.07.001", "ArticleIdList": ["10.1016/j.jcrpr.2017.07.001"]}, {"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. 10.3322/caac.21492", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353. 10.1002/ijc.31937", "ArticleIdList": ["10.1002/ijc.31937", "30350310"]}, {"Citation": "Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, et al. Potential of zerumbone as an anti-cancer agent. Molecules. 2019;24:734. 10.3390/molecules24040734", "ArticleIdList": ["10.3390/molecules24040734", "PMC6413012", "30781671"]}, {"Citation": "Henamayee S, Banik K, Sailo BL, Shabnam B, Harsha C, Srilakshmi S, et al. Therapeutic emergence of rhein as a potential anticancer drug: a review of its molecular targets and anticancer properties. Molecules. 2020;25:2278. 10.3390/molecules25102278", "ArticleIdList": ["10.3390/molecules25102278", "PMC7288145", "32408623"]}, {"Citation": "Khatoon E, Banik K, Harsha C, Sailo BL, Thakur KK, Khwairakpam AD, et al. Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives. Semin Cancer Biol. 2020;[Epub ahead of print]. 10.1016/j.semcancer.2020.06.014", "ArticleIdList": ["10.1016/j.semcancer.2020.06.014", "32610149"]}, {"Citation": "Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25:2097\u2013116. 10.1007/s11095-008-9661-9", "ArticleIdList": ["10.1007/s11095-008-9661-9", "PMC2515569", "18626751"]}, {"Citation": "Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269:199\u2013225. 10.1016/j.canlet.2008.03.009", "ArticleIdList": ["10.1016/j.canlet.2008.03.009", "18479807"]}, {"Citation": "Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci (Lond). 2017;131:1781\u201399. 10.1042/CS20160935", "ArticleIdList": ["10.1042/CS20160935", "28679846"]}, {"Citation": "Roy NK, Bordoloi D, Monisha J, Padmavathi G, Kotoky J, Golla R, et al. Specific targeting of Akt kinase isoforms: taking the precise path for prevention and treatment of cancer. Curr Drug Targets. 2017;18:421\u201335. 10.2174/1389450117666160307145236", "ArticleIdList": ["10.2174/1389450117666160307145236", "26953242"]}, {"Citation": "Shabnam B, Padmavathi G, Banik K, Girisa S, Monisha J, Sethi G, et al. Sorcin a potential molecular target for cancer therapy. Transl Oncol. 2018;11:1379\u201389. 10.1016/j.tranon.2018.08.015", "ArticleIdList": ["10.1016/j.tranon.2018.08.015", "PMC6134165", "30216763"]}, {"Citation": "Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, et al. Honokiol for cancer therapeutics: a traditional medicine that can modulate multiple oncogenic targets. Pharmacol Res. 2019;144:192\u2013209. 10.1016/j.phrs.2019.04.004", "ArticleIdList": ["10.1016/j.phrs.2019.04.004", "31002949"]}, {"Citation": "Kunnumakkara AB, Shabnam B, Girisa S, Harsha C, Banik K, Devi TB, et al. Inflammation, NF-\u03baB, and chronic diseases: how are they linked? Crit Rev Immunol. 2020;40:1\u201339. 10.1615/CritRevImmunol.2020033210", "ArticleIdList": ["10.1615/CritRevImmunol.2020033210", "32421977"]}, {"Citation": "Shanmugam MK, Warrier S, Kumar AP, Sethi G, Arfuso F. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol. 2017;15:503\u201319. 10.2174/1570161115666170713094319", "ArticleIdList": ["10.2174/1570161115666170713094319", "28707601"]}, {"Citation": "Hsieh YS, Yang SF, Sethi G, Hu DN. Natural bioactives in cancer treatment and prevention. Biomed Res Int. 2015;2015:182835. 10.1155/2015/182835", "ArticleIdList": ["10.1155/2015/182835", "PMC4391150", "25883943"]}, {"Citation": "Dai X, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, et al. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy. Exp Biol Med (Maywood). 2015;240:760\u201373. 10.1177/1535370215579167", "ArticleIdList": ["10.1177/1535370215579167", "PMC4935211", "25854879"]}, {"Citation": "Khwairakpam AD, Shyamananda MS, Sailo BL, Rathnakaram SR, Padmavathi G, Kotoky J, et al. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. Curr Drug Targets. 2015;16:156\u201363. 10.2174/1389450115666141224125117", "ArticleIdList": ["10.2174/1389450115666141224125117", "25537655"]}, {"Citation": "Sailo BL, Banik K, Girisa S, Bordoloi D, Fan L, Halim CE, et al. FBXW7 in cancer: what has been unraveled thus far? Cancers (Basel). 2019;11:246. 10.3390/cancers11020246", "ArticleIdList": ["10.3390/cancers11020246", "PMC6406609", "30791487"]}, {"Citation": "Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P. Potential of spice-derived phytochemicals for cancer prevention. Planta Med. 2008;74:1560\u20139. 10.1055/s-2008-1074578", "ArticleIdList": ["10.1055/s-2008-1074578", "18612945"]}, {"Citation": "Guruvayoorappan C, Sakthivel KM, Padmavathi G, Bakliwal V, Monisha J, Kunnumakkara AB. Cancer preventive and therapeutic properties of fruits and vegetables: an overview. In: Kunnumakkara AB.editors. Anticancer properties of fruits and vegetable: Scientific Review. Singapore: World Scientific; 2015. pp. 1\u201352."}, {"Citation": "Roy PS, Saikia BJ. Cancer and cure: a critical analysis. Indian J Cancer. 2016;53:441\u20132. 10.4103/0019-509X.200658", "ArticleIdList": ["10.4103/0019-509X.200658", "28244479"]}, {"Citation": "Chakraborty C, Sharma AR, Sharma G, Sarkar BK, Lee SS. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget. 2018;9:10164\u201374. 10.18632/oncotarget.24309", "ArticleIdList": ["10.18632/oncotarget.24309", "PMC5839381", "29515800"]}, {"Citation": "Ranaware AM, Banik K, Deshpande V, Padmavathi G, Roy NK, Sethi G, et al. Magnolol: a neolignan from the magnolia family for the prevention and treatment of cancer. Int J Mol Sci. 2018;19:2362. 10.3390/ijms19082362", "ArticleIdList": ["10.3390/ijms19082362", "PMC6121321", "30103472"]}, {"Citation": "Arruebo M, Vilaboa N, S\u00e1ez-Gutierrez B, Lambea J, Tres A, Valladares M, et al. Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2011;3:3279\u2013330. 10.3390/cancers3033279", "ArticleIdList": ["10.3390/cancers3033279", "PMC3759197", "24212956"]}, {"Citation": "Kanojia D, Garg M, Martinez J, M TA, Luty SB, Doan NB, et al. Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets. J Hematol Oncol. 2017;10:173. 10.1186/s13045-017-0540-x", "ArticleIdList": ["10.1186/s13045-017-0540-x", "PMC5683536", "29132397"]}, {"Citation": "Warrier VU, Makandar AI, Garg M, Sethi G, Kant R, Pal JK, et al. Engineering anti-cancer nanovaccine based on antigen cross-presentation. Biosci Rep. 2019;39:BSR20193220. 10.1042/BSR20193220", "ArticleIdList": ["10.1042/BSR20193220", "PMC6822533", "31652460"]}, {"Citation": "Garg M, Nagata Y, Kanojia D, Mayakonda A, Yoshida K, Haridas Keloth S, et al. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood. 2015;126:2491\u2013501. 10.1182/blood-2015-05-646240", "ArticleIdList": ["10.1182/blood-2015-05-646240", "PMC4661172", "26438511"]}, {"Citation": "Kirtonia A, Gala K, Fernandes SG, Pandya G, Pandey AK, Sethi G, et al. Repurposing of drugs: an attractive pharmacological strategy for cancer therapeutics. Semin Cancer Biol. 2020;[Epub ahead of print]. 10.1016/j.semcancer.2020.04.006", "ArticleIdList": ["10.1016/j.semcancer.2020.04.006", "32380233"]}, {"Citation": "Kirtonia A, Pandya G, Sethi G, Pandey AK, Das BC, Garg M. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. J Mol Med (Berl). 2020;98:1069\u201391. 10.1007/s00109-020-01944-5", "ArticleIdList": ["10.1007/s00109-020-01944-5", "32620999"]}, {"Citation": "Monisha J, Padmavathi G, Roy NK, Deka A, Bordoloi D, Anip A, et al. NF-\u03baB blockers gifted by mother nature: prospectives in cancer cell chemosensitization. Curr Pharm Des. 2016;22:4173\u2013200. 10.2174/1381612822666160609110231", "ArticleIdList": ["10.2174/1381612822666160609110231", "27291284"]}, {"Citation": "Roy NK, Deka A, Bordoloi D, Mishra S, Kumar AP, Sethi G, et al. The potential role of boswellic acids in cancer prevention and treatment. Cancer Lett. 2016;377:74\u201386. 10.1016/j.canlet.2016.04.017", "ArticleIdList": ["10.1016/j.canlet.2016.04.017", "27091399"]}, {"Citation": "Khwairakpam AD, Bordoloi D, Thakur KK, Monisha J, Arfuso F, Sethi G, et al. Possible use of Punica granatum (Pomegranate) in cancer therapy. Pharmacol Res. 2018;133:53\u201364. 10.1016/j.phrs.2018.04.021", "ArticleIdList": ["10.1016/j.phrs.2018.04.021", "29729421"]}, {"Citation": "Monisha J, Jaiswal A, Banik K, Choudhary H, Singh AK, Bordoloi D, et al. Cancer cell chemoresistance: a prime obstacle in cancer therapy. In: Kunnumakkara AB, Bordoloi D, Monisha J.editors. Cancer cell chemoresistance and chemosensitization. Sinapore: World Scientific; 2018. pp. 15\u201349."}, {"Citation": "Banik K, Ranaware AM, Harsha C, Nitesh T, Girisa S, Deshpande V, et al. Piceatannol: a natural stilbene for the prevention and treatment of cancer. Pharmacol Res. 2020;153:104635. 10.1016/j.phrs.2020.104635", "ArticleIdList": ["10.1016/j.phrs.2020.104635", "31926274"]}, {"Citation": "Kunnumakkara AB, Nair AS, Ahn KS, Pandey MK, Yi Z, Liu M, et al. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood. 2007;109:5112\u201321. 10.1182/blood-2007-01-067256", "ArticleIdList": ["10.1182/blood-2007-01-067256", "PMC1890830", "17332240"]}, {"Citation": "Bordoloi D, Roy NK, Monisha J, Padmavathi G, Kunnumakkara AB. Multi-targeted agents in cancer cell chemosensitization: what we learnt from curcumin thus far. Recent Pat Anticancer Drug Discov. 2016;11:67\u201397. 10.2174/1574892810666151020101706", "ArticleIdList": ["10.2174/1574892810666151020101706", "26537958"]}, {"Citation": "Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB. Tocotrienols: the promising analogues of vitamin E for cancer therapeutics. Pharmacol Res. 2018;130:259\u201372. 10.1016/j.phrs.2018.02.017", "ArticleIdList": ["10.1016/j.phrs.2018.02.017", "29496592"]}, {"Citation": "Kunnumakkara AB, Bordoloi D, Sailo BL, Roy NK, Thakur KK, Banik K, et al. Cancer drug development: the missing links. Exp Biol Med (Maywood). 2019;244:663\u201389. 10.1177/1535370219839163", "ArticleIdList": ["10.1177/1535370219839163", "PMC6552400", "30961357"]}, {"Citation": "Thomas D, Govindhan S, Baiju EC, Padmavathi G, Kunnumakkara AB, Padikkala J. Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stress. J Basic Clin Physiol Pharmacol. 2015;26:485\u201390. 10.1515/jbcpp-2014-0093", "ArticleIdList": ["10.1515/jbcpp-2014-0093", "25915081"]}, {"Citation": "Deng S, Shanmugam MK, Kumar AP, Yap CT, Sethi G, Bishayee A. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 2019;125:1228\u201346. 10.1002/cncr.31978", "ArticleIdList": ["10.1002/cncr.31978", "30748003"]}, {"Citation": "Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov AG, et al. Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention. Pharmacol Res. 2018;128:366\u201375. 10.1016/j.phrs.2017.09.014", "ArticleIdList": ["10.1016/j.phrs.2017.09.014", "28951297"]}, {"Citation": "Mishra S, Verma SS, Rai V, Awasthee N, Chava S, Hui KM, et al. Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases. Cell Mol Life Sci. 2019;76:1947\u201366. 10.1007/s00018-019-03053-0", "ArticleIdList": ["10.1007/s00018-019-03053-0", "PMC7775409", "30879091"]}, {"Citation": "Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood. 2007;110:3517\u201325. 10.1182/blood-2007-03-079616", "ArticleIdList": ["10.1182/blood-2007-03-079616", "PMC2077305", "17673602"]}, {"Citation": "Khwairakpam AD, Monisha J, Roy NK, Bordoloi D, Padmavathi G, Banik K, et al. Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma. J Basic Clin Physiol Pharmacol. 2019;31:/j/jbcpp.2020.31.issue-3/jbcpp-2019-0162/jbcpp-2019-0162.xml. 10.1515/jbcpp-2019-0162", "ArticleIdList": ["10.1515/jbcpp-2019-0162", "31747377"]}, {"Citation": "Padmavathi G, Rathnakaram SR, Monisha J, Bordoloi D, Roy NK, Kunnumakkara AB. Potential of butein, a tetrahydroxychalcone to obliterate cancer. Phytomedicine. 2015;22:1163\u201371. 10.1016/j.phymed.2015.08.015", "ArticleIdList": ["10.1016/j.phymed.2015.08.015", "26598915"]}, {"Citation": "Padmavathi G, Roy NK, Bordoloi D, Arfuso F, Mishra S, Sethi G, et al. Butein in health and disease: a comprehensive review. Phytomedicine. 2017;25:118\u201327. 10.1016/j.phymed.2016.12.002", "ArticleIdList": ["10.1016/j.phymed.2016.12.002", "28190465"]}, {"Citation": "Banik K, Harsha C, Bordoloi D, Lalduhsaki Sailo B, Sethi G, Leong HC, et al. Therapeutic potential of gambogic acid, a caged xanthone, to target cancer. Cancer Lett. 2018;416:75\u201386. 10.1016/j.canlet.2017.12.014", "ArticleIdList": ["10.1016/j.canlet.2017.12.014", "29246645"]}, {"Citation": "Khwairakpam AD, Damayenti YD, Deka A, Monisha J, Roy NK, Padmavathi G, et al. Acorus calamus: a bio-reserve of medicinal values. J Basic Clin Physiol Pharmacol. 2018;29:107\u201322. 10.1515/jbcpp-2016-0132", "ArticleIdList": ["10.1515/jbcpp-2016-0132", "29389665"]}, {"Citation": "Bordoloi D, Monisha J, Roy NK, Padmavathi G, Banik K, Harsha C, et al. An investigation on the therapeutic potential of butein, a tretrahydroxychalcone against human oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2019;20:3437\u201346. 10.31557/APJCP.2019.20.11.3437", "ArticleIdList": ["10.31557/APJCP.2019.20.11.3437", "PMC7063020", "31759370"]}, {"Citation": "Roy NK, Parama D, Banik K, Bordoloi D, Devi AK, Thakur KK, et al. An update on pharmacological potential of boswellic acids against chronic diseases. Int J Mol Sci. 2019;20:4101. 10.3390/ijms20174101", "ArticleIdList": ["10.3390/ijms20174101", "PMC6747466", "31443458"]}, {"Citation": "Singh YP, Girisa S, Banik K, Ghosh S, Swathi P, Deka M, et al. Potential application of zerumbone in the prevention and therapy of chronic human diseases. J Funct Foods. 2019;53:248\u201358. 10.1016/j.jff.2018.12.020", "ArticleIdList": ["10.1016/j.jff.2018.12.020"]}, {"Citation": "Prasannan R, Kalesh KA, Shanmugam MK, Nachiyappan A, Ramachandran L, Nguyen AH, et al. Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem Pharmacol. 2012;84:1268\u201376. 10.1016/j.bcp.2012.07.015", "ArticleIdList": ["10.1016/j.bcp.2012.07.015", "22842489"]}, {"Citation": "Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, et al. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget. 2014;5:1897\u2013911. 10.18632/oncotarget.1876", "ArticleIdList": ["10.18632/oncotarget.1876", "PMC4039111", "24722367"]}, {"Citation": "Ramachandran L, Manu KA, Shanmugam MK, Li F, Siveen KS, Vali S, et al. Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor \u03b3 activation pathway in gastric cancer. J Biol Chem. 2012;287:38028\u201340. 10.1074/jbc.M112.388702", "ArticleIdList": ["10.1074/jbc.M112.388702", "PMC3488073", "22992727"]}, {"Citation": "Manu KA, Shanmugam MK, Ramachandran L, Li F, Siveen KS, Chinnathambi A, et al. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-\u03baB signaling cascade in gastric cancer. Cancer Lett. 2015;363:28\u201336. 10.1016/j.canlet.2015.03.033", "ArticleIdList": ["10.1016/j.canlet.2015.03.033", "25827070"]}, {"Citation": "Lee JH, Chiang SY, Nam D, Chung WS, Lee J, Na YS, et al. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer Lett. 2014;345:140\u20138. 10.1016/j.canlet.2013.12.008", "ArticleIdList": ["10.1016/j.canlet.2013.12.008", "24333736"]}, {"Citation": "Yamada T, Sugimoto K. Guggulsterone and its role in chronic diseases. Adv Exp Med Biol. 2016;929:329\u201361. 10.1007/978-3-319-41342-6_15", "ArticleIdList": ["10.1007/978-3-319-41342-6_15", "27771932"]}, {"Citation": "Urizar NL, Moore DD. GUGULIPID: a natural cholesterol-lowering agent. Annu Rev Nutr. 2003;23:303\u201313. 10.1146/annurev.nutr.23.011702.073102", "ArticleIdList": ["10.1146/annurev.nutr.23.011702.073102", "12626688"]}, {"Citation": "Soni V, Swarnkar PL. Conservation strategies for Commiphora wightii. An important medicinal plant species. Medicinal Plant Conservation. 2006;12:40\u20132."}, {"Citation": "Deng R. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovasc Drug Rev. 2007;25:375\u201390. 10.1111/j.1527-3466.2007.00023.x", "ArticleIdList": ["10.1111/j.1527-3466.2007.00023.x", "18078436"]}, {"Citation": "Ghritlahare SK, Satapathy T, Panda PK, Mishra G. Ethnopharmacological story of guggul sterones: an overview. Res J Pharmacognosy and Phytochem. 2017;9:182\u20138. 10.5958/0975-4385.2017.00034.6", "ArticleIdList": ["10.5958/0975-4385.2017.00034.6"]}, {"Citation": "Jain N, Nadgauda R. Commiphora wightii (Arnott) Bhandari-a natural source of guggulsterone: facing a high risk of extinction in its natural habitat. Am J Plant Sci. 2013;04:57\u201368. 10.4236/ajps.2013.46A009", "ArticleIdList": ["10.4236/ajps.2013.46A009"]}, {"Citation": "Almazari I, Surh YJ. Cancer chemopreventive and therapeutic potential of guggulsterone. Top Curr Chem. 2013;329:35\u201360. 10.1007/128_2012_344", "ArticleIdList": ["10.1007/128_2012_344", "22851157"]}, {"Citation": "Shishodia S, Azu N, Rosenzweig JA, Jackson DA. Guggulsterone for chemoprevention of cancer. Curr Pharm Des. 2016;22:294\u2013306. 10.2174/1381612822666151112153117", "ArticleIdList": ["10.2174/1381612822666151112153117", "26561056"]}, {"Citation": "Shishodia S, Aggarwal BB. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem. 2004;279:47148\u201358. 10.1074/jbc.M408093200", "ArticleIdList": ["10.1074/jbc.M408093200", "15322087"]}, {"Citation": "Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R. Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells. PLoS One. 2011;6:e14728. 10.1371/journal.pone.0014728", "ArticleIdList": ["10.1371/journal.pone.0014728", "PMC3044714", "21383988"]}, {"Citation": "Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, Batra SK, et al. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett. 2013;341:166\u201377. 10.1016/j.canlet.2013.07.037", "ArticleIdList": ["10.1016/j.canlet.2013.07.037", "PMC3825785", "23920124"]}, {"Citation": "Liu X, Guo GL, Kong B, Hilburn DB, Hubchak SC, Park S, et al. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice. Hepatology. 2018;68:304\u201316. 10.1002/hep.29815", "ArticleIdList": ["10.1002/hep.29815", "PMC6033648", "29377207"]}, {"Citation": "Owsley E, Chiang JY. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene. Biochem Biophys Res Commun. 2003;304:191\u20135. 10.1016/s0006-291x(03)00551-5", "ArticleIdList": ["10.1016/s0006-291x(03)00551-5", "12705905"]}, {"Citation": "Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in cancer. Cancer Res. 2016;76:2063\u201370. 10.1158/0008-5472.CAN-15-2613", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2613", "PMC5813477", "27197250"]}, {"Citation": "Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet. 1992;339:1154\u20136. 10.1016/0140-6736(92)90744-n", "ArticleIdList": ["10.1016/0140-6736(92)90744-n", "1349377"]}, {"Citation": "An MJ, Cheon JH, Kim SW, Kim ES, Kim TI, Kim WH. Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts. Cancer Lett. 2009;279:93\u2013100. 10.1016/j.canlet.2009.01.026", "ArticleIdList": ["10.1016/j.canlet.2009.01.026", "19232820"]}, {"Citation": "Witkamp R. Biologically active compounds in food products and their effects on obesity and diabetes. Comprehensive natural products II: Chemistry and biology. Oxford: Elsevier; 2010. pp. 509\u201345."}, {"Citation": "Jasuja ND, Choudhary J, Sharama P, Sharma N, Joshi SC. A review on bioactive compounds and medicinal uses of Commiphora mukul. J Plant Sci. 2012;7:113\u201337. 10.3923/jps.2012.113.137", "ArticleIdList": ["10.3923/jps.2012.113.137"]}, {"Citation": "Shah R, Gulati V, Palombo EA. Pharmacological properties of guggulsterones, the major active components of gum guggul. Phytother Res. 2012;26:1594\u2013605. 10.1002/ptr.4647", "ArticleIdList": ["10.1002/ptr.4647", "22388973"]}, {"Citation": "Shishodia S, Harikumar KB, Dass S, Ramawat KG, Aggarwal BB. The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res. 2008;28:3647\u201364.", "ArticleIdList": ["19189646"]}, {"Citation": "Bajaj AG, Dev S. Chemistry of ayurvedic crude drugs-V: Guggulu (resin from commiphora mukul)-5 some new steroidal components and, stereochemistry of guggulsterol-I at C-20 and C-22. Tetrahedron. 1982;38:2949\u201354. 10.1016/0040-4020(82)85024-2", "ArticleIdList": ["10.1016/0040-4020(82)85024-2"]}, {"Citation": "Shen T, Li GH, Wang XN, Lou HX. The genus Commiphora: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2012;142:319\u201330. 10.1016/j.jep.2012.05.025", "ArticleIdList": ["10.1016/j.jep.2012.05.025", "22626923"]}, {"Citation": "Kunnumakkara AB, Banik K, Bordoloi D, Harsha C, Sailo BL, Padmavathi G, et al. Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases. Front Pharmacol. 2018;9:686. 10.3389/fphar.2018.00686", "ArticleIdList": ["10.3389/fphar.2018.00686", "PMC6087759", "30127736"]}, {"Citation": "Ojha S, Bhatia J, Arora S, Golechha M, Kumari S, Arya DS. Cardioprotective effects of Commiphora mukul against isoprenaline-induced cardiotoxicity: a biochemical and histopathological evaluation. J Environ Biol. 2011;32:731\u20138.", "ArticleIdList": ["22471209"]}, {"Citation": "Rupani R, Chavez A. Medicinal plants with traditional use: ethnobotany in the Indian subcontinent. Clin Dermatol. 2018;36:306\u20139. 10.1016/j.clindermatol.2018.03.005", "ArticleIdList": ["10.1016/j.clindermatol.2018.03.005", "29908572"]}, {"Citation": "Sharma A, Kumar A. Traditional uses of herbal medicinal plants of Rajashthan: Guggal. Int J Life Sci Pharma Res. 2012;2:77\u201382."}, {"Citation": "Baliga MS, Nandhini J, Emma F, Venkataranganna MV, Venkatesh P, Fayad R. Indian medicinal plants and spices in the prevention and treatment of ulcerative colitis. In: Watson R, Preedy V.editors. Bioactive food as dietary interventions for liver and gastrointestinal disease. San Diego: Academic Press; 2013. pp. 173\u201385."}, {"Citation": "Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 2002;296:1703\u20136. 10.1126/science.1072891", "ArticleIdList": ["10.1126/science.1072891", "11988537"]}, {"Citation": "Agrawal P, Vegda R, Laddha K. Simultaneous estimation of Withaferin A and Z-Guggulsterone in marketed formulation by RP-HPLC. J Chromatogr Sci. 2015;53:940\u20134. 10.1093/chromsci/bmu153", "ArticleIdList": ["10.1093/chromsci/bmu153", "25572656"]}, {"Citation": "Nadeem S. Synergistic effect of Commiphora mukul (gum resin) and Lagenaria siceraria (fruit) extracts in high fat diet induced obese rats. Asian Pac J Trop Dis. 2012;2:S883\u20136. 10.1016/S2222-1808(12)60285-0", "ArticleIdList": ["10.1016/S2222-1808(12)60285-0", "22805720"]}, {"Citation": "Rehman NU, Al-Riyami SA, Hussain H, Ali A, Khan AL, Al-Harrasi A. Secondary metabolites from the resins of Aloe vera and Commiphora mukul mitigate lipid peroxidation. Acta Pharm. 2019;69:433\u201341. 10.2478/acph-2019-0027", "ArticleIdList": ["10.2478/acph-2019-0027", "31259740"]}, {"Citation": "Ramesh B, Karuna R, Sreenivasa RS, Haritha K, Sai MD, Sasi BR, et al. Effect of Commiphora mukul gum resin on hepatic marker enzymes, lipid peroxidation and antioxidants status in pancreas and heart of streptozotocin induced diabetic rats. Asian Pac J Trop Biomed. 2012;2:895\u2013900. 10.1016/S2221-1691(12)60249-4", "ArticleIdList": ["10.1016/S2221-1691(12)60249-4", "PMC3609238", "23569867"]}, {"Citation": "Cornick CL, Strongitharm BH, Sassano G, Rawlins C, Mayes AE, Joseph AN, et al. Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice. J Nutr Biochem. 2009;20:806\u201315. 10.1016/j.jnutbio.2008.07.010", "ArticleIdList": ["10.1016/j.jnutbio.2008.07.010", "18926687"]}, {"Citation": "Wang XW, Yu Y, Gu L. Dehydroabietic acid reverses TNF-\u03b1-induced the activation of FOXO1 and suppression of TGF-\u03b21/Smad signaling in human adult dermal fibroblasts. Int J Clin Exp Pathol. 2014;7:8616\u201326.", "ArticleIdList": ["PMC4314026", "25674226"]}, {"Citation": "Goyal S, Khilnani G, Singhvi I, Singla S, Khilnani AK. Guggulipid of Commiphora mukul, with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain. Pharm Biol. 2013;51:1487\u201398. 10.3109/13880209.2013.796392", "ArticleIdList": ["10.3109/13880209.2013.796392", "23862659"]}, {"Citation": "Ahmad MA, Najmi AK, Mujeeb M, Akhtar M. Protective effect of guggulipid in high fat diet and middle cerebral artery occlusion (MCAO) induced ischemic cerebral injury in rats. Drug Res (Stuttg). 2016;66:407\u201314. 10.1055/s-0042-107787", "ArticleIdList": ["10.1055/s-0042-107787", "27224907"]}, {"Citation": "Niranjan R, Nath C, Shukla R. Guggulipid and nimesulide differentially regulated inflammatory genes mRNA expressions via inhibition of NF-kB and CHOP activation in LPS-stimulated rat astrocytoma cells, C6. Cell Mol Neurobiol. 2011;31:755\u201364. 10.1007/s10571-011-9684-3", "ArticleIdList": ["10.1007/s10571-011-9684-3", "21461920"]}, {"Citation": "Singh SV, Zeng Y, Xiao D, Vogel VG, Nelson JB, Dhir R, et al. Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol Cancer Ther. 2005;4:1747\u201354. 10.1158/1535-7163.MCT-05-0223", "ArticleIdList": ["10.1158/1535-7163.MCT-05-0223", "16275996"]}, {"Citation": "Shen T, Zhang L, Wang YY, Fan PH, Wang XN, Lin ZM, et al. Steroids from Commiphora mukul display antiproliferative effect against human prostate cancer PC3 cells via induction of apoptosis. Bioorg Med Chem Lett. 2012;22:4801\u20136. 10.1016/j.bmcl.2012.05.052", "ArticleIdList": ["10.1016/j.bmcl.2012.05.052", "22687747"]}, {"Citation": "Mallavadhani UV, Chandrashekhar M, Nayak VL, Ramakrishna S. Synthesis and anticancer activity of novel fused pyrimidine hybrids of myrrhanone C, a bicyclic triterpene of Commiphora mukul gum resin. Mol Divers. 2015;19:745\u201357. 10.1007/s11030-015-9621-3", "ArticleIdList": ["10.1007/s11030-015-9621-3", "26232027"]}, {"Citation": "Saeed MA, Sabir AW. Antibacterial activities of some constituents from oleo-gum-resin of Commiphora mukul. Fitoterapia. 2004;75:204\u20138. 10.1016/j.fitote.2003.12.003", "ArticleIdList": ["10.1016/j.fitote.2003.12.003", "15030926"]}, {"Citation": "Haffor AS. Effect of myrrh (Commiphora molmol) on leukocyte levels before and during healing from gastric ulcer or skin injury. J Immunotoxicol. 2010;7:68\u201375. 10.3109/15476910903409835", "ArticleIdList": ["10.3109/15476910903409835", "19995243"]}, {"Citation": "Saxena G, Singh SP, Pal R, Singh S, Pratap R, Nath C. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol Biochem Behav. 2007;86:797\u2013805. 10.1016/j.pbb.2007.03.010", "ArticleIdList": ["10.1016/j.pbb.2007.03.010", "17477963"]}, {"Citation": "Gujral ML, Sareen K, Tangri KK, Amma MK, Roy AK. Antiarthritic and anti-inflammatory activity of gum guggul (Balsamodendron mukul Hook). Indian J Physiol Pharmacol. 1960;4:267\u201373.", "ArticleIdList": ["13709695"]}, {"Citation": "Dini I. Spices and herbs as therapeutic foods. In: Grumezescu A, Holban AM.editors. Food quality: balancing health and disease. San Diego: Academic Press; 2018. pp. 433\u201369."}, {"Citation": "Chander R, Rizvi F, Khanna AK, Pratap R. Cardioprotective activity of synthetic guggulsterone (E and Z-isomers) in isoproterenol induced myocardial ischemia in rats: a comparative study. Indian J Clin Biochem. 2003;18:71\u20139. 10.1007/BF02867370", "ArticleIdList": ["10.1007/BF02867370", "PMC3453889", "23105395"]}, {"Citation": "Kalshetti PB, Thakurdesai P, Alluri R. A review on bioactive phytoconstituents and pharmacological uses of Commiphora mukul. J Curr Pharma Res. 2014;5:1392\u2013405."}, {"Citation": "Kulhari A, Sheorayan A, Chaudhury A, Sarkar S, Kalia RK. Quantitative determination of guggulsterone in existing natural populations of Commiphora wightii (Arn.) Bhandari for identification of germplasm having higher guggulsterone content. Physiol Mol Biol Plants. 2015;21:71\u201381. 10.1007/s12298-014-0271-1", "ArticleIdList": ["10.1007/s12298-014-0271-1", "PMC4312330", "25648764"]}, {"Citation": "De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, et al. Expression of the bile acid receptor FXR in Barrett\u2019s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer. 2006;5:48. 10.1186/1476-4598-5-48", "ArticleIdList": ["10.1186/1476-4598-5-48", "PMC1624849", "17054793"]}, {"Citation": "Kainuma M, Takada I, Makishima M, Sano K. Farnesoid X receptor activation enhances transforming growth factor \u03b2-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells. Int J Mol Sci. 2018;19:1898. 10.3390/ijms19071898", "ArticleIdList": ["10.3390/ijms19071898", "PMC6073264", "29958417"]}, {"Citation": "Absil L, Journ\u00e9 F, Larsimont D, Body JJ, Tafforeau L, Nonclercq D. Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells. BMC Cancer. 2020;20:640. 10.1186/s12885-020-07106-7", "ArticleIdList": ["10.1186/s12885-020-07106-7", "PMC7350202", "32650752"]}, {"Citation": "Leeman-Neill RJ, Wheeler SE, Singh SV, Thomas SM, Seethala RR, Neill DB, et al. Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis. 2009;30:1848\u201356. 10.1093/carcin/bgp211", "ArticleIdList": ["10.1093/carcin/bgp211", "PMC2783003", "19762335"]}, {"Citation": "Ahn KS, Sethi G, Sung B, Goel A, Ralhan R, Aggarwal BB. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res. 2008;68:4406\u201315. Erratum in: Cancer Res. 2018;78:5184. 10.1158/0008-5472.CAN-07-6696", "ArticleIdList": ["10.1158/0008-5472.CAN-07-6696", "18519703"]}, {"Citation": "Kim ES, Hong SY, Lee HK, Kim SW, An MJ, Kim TI, et al. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Oncol Rep. 2008;20:1321\u20137.", "ArticleIdList": ["19020709"]}, {"Citation": "Zhong F, Yang J, Tong ZT, Chen LL, Fan LL, Wang F, et al. Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression. Oncol Lett. 2015;10:1416\u201322. 10.3892/ol.2015.3391", "ArticleIdList": ["10.3892/ol.2015.3391", "PMC4533301", "26622683"]}, {"Citation": "Shishodia S, Sethi G, Ahn KS, Aggarwal BB. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol. 2007;74:118\u201330. 10.1016/j.bcp.2007.03.026", "ArticleIdList": ["10.1016/j.bcp.2007.03.026", "PMC2744036", "17475222"]}, {"Citation": "Yamada T, Osawa S, Hamaya Y, Furuta T, Hishida A, Kajimura M, et al. Guggulsterone suppresses bile acid-induced and constitutive caudal-related homeobox 2 expression in gut-derived adenocarcinoma cells. Anticancer Res. 2010;30:1953\u201360.", "ArticleIdList": ["20651339"]}, {"Citation": "Kim BH, Yoon JH, Yang JI, Myung SJ, Lee JH, Jung EU, et al. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis. J Gastroenterol Hepatol. 2013;28:1859\u201368. 10.1111/jgh.12314", "ArticleIdList": ["10.1111/jgh.12314", "23808824"]}, {"Citation": "Yamada T, Osawa S, Ikuma M, Kajimura M, Sugimoto M, Furuta T, et al. Guggulsterone, a plant-derived inhibitor of NF-TB, suppresses CDX2 and COX-2 expression and reduces the viability of esophageal adenocarcinoma cells. Digestion. 2014;90:208\u201317. 10.1159/000365750", "ArticleIdList": ["10.1159/000365750", "25427631"]}, {"Citation": "Ichikawa H, Aggarwal BB. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin Cancer Res. 2006;12:662\u20138. Erratum in: Clin Cancer Res. 2018;24:4347. 10.1158/1078-0432.CCR-05-1749", "ArticleIdList": ["10.1158/1078-0432.CCR-05-1749", "16428513"]}, {"Citation": "Noh EM, Chung EY, Youn HJ, Jung SH, Hur H, Lee YR, et al. Cis-guggulsterone inhibits the IKK/NF-\u03baB pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF-7 breast cancer cells: guggulsterone regulates MMP-9 expression in an isomer-specific manner. Int J Mol Med. 2013;31:393\u20139. 10.3892/ijmm.2012.1214", "ArticleIdList": ["10.3892/ijmm.2012.1214", "23242121"]}, {"Citation": "Puar YR, Shanmugam MK, Fan L, Arfuso F, Sethi G, Tergaonkar V. Evidence for the involvement of the master transcription factor NF-\u03baB in cancer initiation and progression. Biomedicines. 2018;6:82. 10.3390/biomedicines6030082", "ArticleIdList": ["10.3390/biomedicines6030082", "PMC6163404", "30060453"]}, {"Citation": "Shin EM, Hay HS, Lee MH, Goh JN, Tan TZ, Sen YP, et al. DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest. 2014;124:3807\u201324. 10.1172/JCI73451", "ArticleIdList": ["10.1172/JCI73451", "PMC4151228", "25083991"]}, {"Citation": "Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB. Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer. 2008;123:1733\u201340. 10.1002/ijc.23745", "ArticleIdList": ["10.1002/ijc.23745", "18688862"]}, {"Citation": "Sethi G, Ahn KS, Sung B, Aggarwal BB. Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol Cancer Ther. 2008;7:1604\u201314. 10.1158/1535-7163.MCT-07-2424", "ArticleIdList": ["10.1158/1535-7163.MCT-07-2424", "18566231"]}, {"Citation": "Ahn KS, Sethi G, Jain AK, Jaiswal AK, Aggarwal BB. Genetic deletion of NAD(P)H: quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J Biol Chem. 2006;281:19798\u2013808. 10.1074/jbc.M601162200", "ArticleIdList": ["10.1074/jbc.M601162200", "16682409"]}, {"Citation": "Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-\u03baB and STAT3 pathways in head and neck cancer cells. Carcinogenesis. 2011;32:368\u201380. 10.1093/carcin/bgq278", "ArticleIdList": ["10.1093/carcin/bgq278", "21177768"]}, {"Citation": "Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Mukhtar H. Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice. Carcinogenesis. 2008;29:2011\u20138. 10.1093/carcin/bgn180", "ArticleIdList": ["10.1093/carcin/bgn180", "PMC2722858", "18684729"]}, {"Citation": "Shi JJ, Jia XL, Li M, Yang N, Li YP, Zhang X, et al. Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway. World J Gastroenterol. 2015;21:13277\u201387. 10.3748/wjg.v21.i47.13277", "ArticleIdList": ["10.3748/wjg.v21.i47.13277", "PMC4679759", "26715810"]}, {"Citation": "Leo R, Therachiyil L, Siveen SK, Uddin S, Kulinski M, Buddenkotte J, et al. Protein expression profiling identifies key proteins and pathways involved in growth inhibitory effects exerted by guggulsterone in human colorectal cancer cells. Cancers (Basel). 2019;11:1478. 10.3390/cancers11101478", "ArticleIdList": ["10.3390/cancers11101478", "PMC6826505", "31581454"]}, {"Citation": "Kim DG, Bae GS, Choi SB, Jo IJ, Shin JY, Lee SK, et al. Guggulsterone attenuates cerulein-induced acute pancreatitis via inhibition of ERK and JNK activation. Int Immunopharmacol. 2015;26:194\u2013202. 10.1016/j.intimp.2015.03.030", "ArticleIdList": ["10.1016/j.intimp.2015.03.030", "25843255"]}, {"Citation": "Jiang G, Xiao X, Zeng Y, Nagabhushanam K, Majeed M, Xiao D. Targeting beta-catenin signaling to induce apoptosis in human breast cancer cells by z-guggulsterone and Gugulipid extract of Ayurvedic medicine plant Commiphora mukul. BMC Complement Altern Med. 2013;13:203. 10.1186/1472-6882-13-203", "ArticleIdList": ["10.1186/1472-6882-13-203", "PMC3735424", "23914993"]}, {"Citation": "Xiao D, Zeng Y, Prakash L, Badmaev V, Majeed M, Singh SV. Reactive oxygen species-dependent apoptosis by gugulipid extract of Ayurvedic medicine plant Commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase. Mol Pharmacol. 2011;79:499\u2013507. 10.1124/mol.110.068551", "ArticleIdList": ["10.1124/mol.110.068551", "PMC3061364", "21115635"]}, {"Citation": "Zhong F, Tong ZT, Fan LL, Zha LX, Wang F, Yao MQ, et al. Guggulsterone-induced apoptosis in cholangiocarcinoma cells through ROS/JNK signaling pathway. Am J Cancer Res. 2016;6:226\u201337.", "ArticleIdList": ["PMC4859655", "27186398"]}, {"Citation": "Singh SV, Choi S, Zeng Y, Hahm ER, Xiao D. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res. 2007;67:7439\u201349. 10.1158/0008-5472.CAN-07-0120", "ArticleIdList": ["10.1158/0008-5472.CAN-07-0120", "17671214"]}, {"Citation": "Neal CL, Yu D. 14-3-3 \u03b6 as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets. 2010;14:1343\u201354. 10.1517/14728222.2010.531011", "ArticleIdList": ["10.1517/14728222.2010.531011", "PMC3017465", "21058923"]}, {"Citation": "Macha MA, Matta A, Chauhan S, Siu KM, Ralhan R. 14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells. BMC Cancer. 2010;10:655. 10.1186/1471-2407-10-655", "ArticleIdList": ["10.1186/1471-2407-10-655", "PMC3002356", "21118500"]}, {"Citation": "Chen XZ, Xu HB, Xu LZ, Mao XP, Li L. Guggulsterone regulates the function and expression of P-glycoprotein in rat brain microvessel endothelial cells. Eur J Pharmacol. 2013;718:24\u20139. 10.1016/j.ejphar.2013.09.010", "ArticleIdList": ["10.1016/j.ejphar.2013.09.010", "24041929"]}, {"Citation": "Xu HB, Li L, Liu GQ. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Pharmazie. 2009;64:660\u20135.", "ArticleIdList": ["19947169"]}, {"Citation": "Xu HB, Xu LZ, Li L, Fu J, Mao XP. Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines. Eur J Pharmacol. 2012;694:39\u201344. 10.1016/j.ejphar.2012.06.046", "ArticleIdList": ["10.1016/j.ejphar.2012.06.046", "22960326"]}, {"Citation": "Xu HB, Fu J, Huang F, Yu J. Guggulsterone sensitized drug-resistant human hepatocarcinoma cells to doxorubicin through a Cox-2/P-gp dependent pathway. Eur J Pharmacol. 2017;803:57\u201364. 10.1016/j.ejphar.2017.03.045", "ArticleIdList": ["10.1016/j.ejphar.2017.03.045", "28342979"]}, {"Citation": "Xu HB, Shen ZL, Fu J, Xu LZ. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo. Phytomedicine. 2014;21:1221\u20139. 10.1016/j.phymed.2014.06.003", "ArticleIdList": ["10.1016/j.phymed.2014.06.003", "25172783"]}, {"Citation": "Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Moon IH, et al. Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-\u03baB. J Cancer Res Clin Oncol. 2012;138:1743\u201351. 10.1007/s00432-012-1254-7", "ArticleIdList": ["10.1007/s00432-012-1254-7", "22699931"]}, {"Citation": "Dixit D, Ghildiyal R, Anto NP, Ghosh S, Sharma V, Sen E. Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NF\u03baB dependent manner. Cancer Lett. 2013;336:347\u201358. 10.1016/j.canlet.2013.03.025", "ArticleIdList": ["10.1016/j.canlet.2013.03.025", "23548480"]}, {"Citation": "Kong JN, He Q, Wang G, Dasgupta S, Dinkins MB, Zhu G, et al. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells. Int J Cancer. 2015;137:1610\u201320. 10.1002/ijc.29542", "ArticleIdList": ["10.1002/ijc.29542", "PMC4503537", "25833198"]}, {"Citation": "Moon DO, Park SY, Choi YH, Ahn JS, Kim GY. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress. Biochem Pharmacol. 2011;82:1641\u201350. 10.1016/j.bcp.2011.08.019", "ArticleIdList": ["10.1016/j.bcp.2011.08.019", "21903093"]}, {"Citation": "Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8:761\u201373. 10.7150/jca.17648", "ArticleIdList": ["10.7150/jca.17648", "PMC5381164", "28382138"]}, {"Citation": "Denton AE, Roberts EW, Fearon DT. Stromal cells in the tumor microenvironment. Adv Exp Med Biol. 2018;1060:99\u2013114. 10.1007/978-3-319-78127-3_6", "ArticleIdList": ["10.1007/978-3-319-78127-3_6", "30155624"]}, {"Citation": "Arneth B. Tumor microenvironment. Medicina (Kaunas). 2019;56:15. 10.3390/medicina56010015", "ArticleIdList": ["10.3390/medicina56010015", "PMC7023392", "31906017"]}, {"Citation": "Libring S, Shinde A, Chanda MK, Nuru M, George H, Saleh AM, et al. The dynamic relationship of breast cancer cells and fibroblasts in fibronectin accumulation at primary and metastatic tumor sites. Cancers (Basel). 2020;12:1270. 10.3390/cancers12051270", "ArticleIdList": ["10.3390/cancers12051270", "PMC7281295", "32429591"]}, {"Citation": "Hardy SD, Shinde A, Wang WH, Wendt MK, Geahlen RL. Regulation of epithelial-mesenchymal transition and metastasis by TGF-\u03b2, P-bodies, and autophagy. Oncotarget. 2017;8:103302\u201314. 10.18632/oncotarget.21871", "ArticleIdList": ["10.18632/oncotarget.21871", "PMC5732729", "29262563"]}, {"Citation": "Shinde A, Libring S, Alpsoy A, Abdullah A, Schaber JA, Solorio L, et al. Autocrine fibronectin inhibits breast cancer metastasis. Mol Cancer Res. 2018;16:1579\u201389. 10.1158/1541-7786.MCR-18-0151", "ArticleIdList": ["10.1158/1541-7786.MCR-18-0151", "PMC6511995", "29934326"]}, {"Citation": "Shinde A, Wilmanski T, Chen H, Teegarden D, Wendt MK. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer. Breast Cancer Res. 2018;20:76. 10.1186/s13058-018-1008-9", "ArticleIdList": ["10.1186/s13058-018-1008-9", "PMC6045837", "30005601"]}, {"Citation": "Shinde A, Hardy SD, Kim D, Akhand SS, Jolly MK, Wang WH, et al. Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer. Cancer Res. 2019;79:1831\u201343. 10.1158/0008-5472.CAN-18-2636", "ArticleIdList": ["10.1158/0008-5472.CAN-18-2636", "PMC6467765", "30733195"]}, {"Citation": "Shinde A, Paez JS, Libring S, Hopkins K, Solorio L, Wendt MK. Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche. Oncogenesis. 2020;9:16. 10.1038/s41389-020-0204-5", "ArticleIdList": ["10.1038/s41389-020-0204-5", "PMC7018754", "32054828"]}, {"Citation": "Uzunalli G, Dieterly AM, Kemet CM, Weng HY, Soepriatna AH, Goergen CJ, et al. Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases. Oncotarget. 2019;10:6334\u201348. 10.18632/oncotarget.27274", "ArticleIdList": ["10.18632/oncotarget.27274", "PMC6824867", "31695842"]}, {"Citation": "Wilmanski T, Zhou X, Zheng W, Shinde A, Donkin SS, Wendt M, et al. Inhibition of pyruvate carboxylase by 1\u03b1,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression. Cancer Lett. 2017;411:171\u201381. 10.1016/j.canlet.2017.09.045", "ArticleIdList": ["10.1016/j.canlet.2017.09.045", "PMC5763507", "29024812"]}, {"Citation": "Wu AA, Drake V, Huang HS, Chiu S, Zheng L. Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. Oncoimmunology. 2015;4:e1016700. 10.1080/2162402X.2015.1016700", "ArticleIdList": ["10.1080/2162402X.2015.1016700", "PMC4485788", "26140242"]}, {"Citation": "Tormoen GW, Crittenden MR, Gough MJ. Role of the immunosuppressive microenvironment in immunotherapy. Adv Radiat Oncol. 2018;3:520\u20136. 10.1016/j.adro.2018.08.018", "ArticleIdList": ["10.1016/j.adro.2018.08.018", "PMC6200899", "30370351"]}, {"Citation": "Xu HB, Li L, Liu GQ. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by guggulsterone. Yao Xue Xue Bao. 2008;43:1190\u20137.", "ArticleIdList": ["19244748"]}, {"Citation": "Gautam A, Paudel YN, Abidin S, Bhandari U. Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: an evidence from in vitro and in vivo studies. Hum Exp Toxicol. 2019;38:356\u201370. 10.1177/0960327118817862", "ArticleIdList": ["10.1177/0960327118817862", "30526076"]}, {"Citation": "Xu Y, Guan J, Xu J, Chen S, Sun G. Z-Guggulsterone attenuates glucocorticoid-induced osteoporosis through activation of Nrf2/HO-1 signaling. Life Sci. 2019;224:58\u201366. 10.1016/j.lfs.2019.03.051", "ArticleIdList": ["10.1016/j.lfs.2019.03.051", "30905781"]}, {"Citation": "Wu K, Zhao T, Hogstrand C, Xu YC, Ling SC, Chen GH, et al. FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity. Cell Commun Signal. 2020;18:47. 10.1186/s12964-020-0525-1", "ArticleIdList": ["10.1186/s12964-020-0525-1", "PMC7082988", "32192487"]}, {"Citation": "Yang R, Hu Z, Zhang P, Wu S, Song Z, Shen X, et al. Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor. J Pharmacol Sci. 2019;139:120\u20138. 10.1016/j.jphs.2018.12.005", "ArticleIdList": ["10.1016/j.jphs.2018.12.005", "30638990"]}, {"Citation": "Id Boufker H, Lagneaux L, Fayyad-Kazan H, Badran B, Najar M, Wiedig M, et al. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone. 2011;49:1219\u201331. 10.1016/j.bone.2011.08.013", "ArticleIdList": ["10.1016/j.bone.2011.08.013", "21893226"]}, {"Citation": "Chen B, You WJ, Xue S, Qin H, Zhao XJ, Zhang M, et al. Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease. J Thorac Dis. 2016;8:3063\u201374. 10.21037/jtd.2016.11.08", "ArticleIdList": ["10.21037/jtd.2016.11.08", "PMC5179405", "28066584"]}, {"Citation": "Khwairakpam AD, Monisha J, Banik K, Choudhary H, Sharma A, Bordoloi D, et al. Chemoresistance in brain cancer and different chemosensitization approaches. In: Kunnumakkara AB, Bordoloi D, Monisha J.editors. Cancer cell chemoresistance and chemosensitization. Singapore: World Scientific; 2018. pp. 107\u201327."}, {"Citation": "Bhuvanalakshmi G, Gamit N, Patil M, Arfuso F, Sethi G, Dharmarajan A, et al. Stemness, pluripotentiality, and Wnt antagonism: sFRP4, a Wnt antagonist mediates pluripotency and stemness in glioblastoma. Cancers (Basel). 2018;11:25. 10.3390/cancers11010025", "ArticleIdList": ["10.3390/cancers11010025", "PMC6356444", "30591679"]}, {"Citation": "Thakur KK, Bordoloi D, Kunnumakkara AB. Alarming burden of triple-negative breast cancer in India. Clin Breast Cancer. 2018;18:e393\u20139. 10.1016/j.clbc.2017.07.013", "ArticleIdList": ["10.1016/j.clbc.2017.07.013", "28801156"]}, {"Citation": "Shanmugam MK, Ahn KS, Hsu A, Woo CC, Yuan Y, Tan KHB, et al. Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis. Front Pharmacol. 2018;9:1294. 10.3389/fphar.2018.01294", "ArticleIdList": ["10.3389/fphar.2018.01294", "PMC6288203", "30564115"]}, {"Citation": "Liu L, Ahn KS, Shanmugam MK, Wang H, Shen H, Arfuso F, et al. Oleuropein induces apoptosis via abrogating NF-\u03baB activation cascade in estrogen receptor-negative breast cancer cells. J Cell Biochem. 2019;120:4504\u201313. 10.1002/jcb.27738", "ArticleIdList": ["10.1002/jcb.27738", "30260018"]}, {"Citation": "Wang C, Kar S, Lai X, Cai W, Arfuso F, Sethi G, et al. Triple negative breast cancer in Asia: an insider\u2019s view. Cancer Treat Rev. 2018;62:29\u201338. 10.1016/j.ctrv.2017.10.014", "ArticleIdList": ["10.1016/j.ctrv.2017.10.014", "29154023"]}, {"Citation": "Bhuvanalakshmi G, Basappa, Rangappa KS, Dharmarajan A, Sethi G, Kumar AP, et al. Breast cancer stem-like cells are inhibited by Diosgenin, a steroidal saponin, by the attenuation of the Wnt \u03b2-Catenin signaling via the Wnt antagonist secreted frizzled related protein-4. Front Pharmacol. 2017;8:124. 10.3389/fphar.2017.00124", "ArticleIdList": ["10.3389/fphar.2017.00124", "PMC5357646", "28373842"]}, {"Citation": "Mohan CD, Srinivasa V, Rangappa S, Mervin L, Mohan S, Paricharak S, et al. Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway. PLoS One. 2016;11:e0153155. 10.1371/journal.pone.0153155", "ArticleIdList": ["10.1371/journal.pone.0153155", "PMC4838272", "27097161"]}, {"Citation": "Jia LY, Shanmugam MK, Sethi G, Bishayee A. Potential role of targeted therapies in the treatment of triple-negative breast cancer. Anticancer Drugs. 2016;27:147\u201355. 10.1097/CAD.0000000000000328", "ArticleIdList": ["10.1097/CAD.0000000000000328", "26682525"]}, {"Citation": "Choudhuri R, Degraff W, Gamson J, Mitchell JB, Cook JA. Guggulsterone-mediated enhancement of radiosensitivity in human tumor cell lines. Front Oncol. 2011;1:19. 10.3389/fonc.2011.00019", "ArticleIdList": ["10.3389/fonc.2011.00019", "PMC3355920", "22649756"]}, {"Citation": "Silva J, Dasgupta S, Wang G, Krishnamurthy K, Ritter E, Bieberich E. Lipids isolated from bone induce the migration of human breast cancer cells. J Lipid Res. 2006;47:724\u201333. 10.1194/jlr.M500473-JLR200", "ArticleIdList": ["10.1194/jlr.M500473-JLR200", "16439808"]}, {"Citation": "Xu HB, Li L, Liu GQ. Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines. Chemotherapy. 2011;57:62\u201370. 10.1159/000321484", "ArticleIdList": ["10.1159/000321484", "21282948"]}, {"Citation": "Buhrmann C, Yazdi M, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Induction of the epithelial-to-mesenchymal transition of human colorectal cancer by human TNF-\u03b2 (Lymphotoxin) and its reversal by resveratrol. Nutrients. 2019;11:704. 10.3390/nu11030704", "ArticleIdList": ["10.3390/nu11030704", "PMC6471988", "30917533"]}, {"Citation": "Buhrmann C, Kunnumakkara AB, Popper B, Majeed M, Aggarwal BB, Shakibaei M. Calebin A potentiates the effect of 5-FU and TNF-\u03b2 (Lymphotoxin \u03b1) against human colorectal cancer cells: potential role of NF-\u03baB. Int J Mol Sci. 2020;21:2393. 10.3390/ijms21072393", "ArticleIdList": ["10.3390/ijms21072393", "PMC7177530", "32244288"]}, {"Citation": "Peng Z, Raufman JP, Xie G. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis. PLoS One. 2012;7:e48461. 10.1371/journal.pone.0048461", "ArticleIdList": ["10.1371/journal.pone.0048461", "PMC3485230", "23119029"]}, {"Citation": "Bordoloi D, Banik K, Khwairakpam AD, Sharma A, Monisha J, Sailo BL, et al. Different approaches to overcome chemoresistance in esophageal cancer. In: Kunnumakkara AB, Bordoloi D, Monisha J.editors. Cancer cell chemoresistance and chemosensitization. Singapore: World Scientific; 2018. pp. 241\u201366."}, {"Citation": "Guan B, Li H, Yang Z, Hoque A, Xu X. Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts. Cancer. 2013;119:1321\u20139. 10.1002/cncr.27910", "ArticleIdList": ["10.1002/cncr.27910", "PMC3604152", "23280144"]}, {"Citation": "Guan B, Hoque A, Xu X. Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts. Front Biol (Beijing). 2014;9:75\u201381. 10.1007/s11515-014-1289-z", "ArticleIdList": ["10.1007/s11515-014-1289-z", "PMC4079079", "24999355"]}, {"Citation": "Elkashty OA, Ashry R, Tran SD. Head and neck cancer management and cancer stem cells implication. Saudi Dent J. 2019;31:395\u2013416. 10.1016/j.sdentj.2019.05.010", "ArticleIdList": ["10.1016/j.sdentj.2019.05.010", "PMC6823822", "31700218"]}, {"Citation": "Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, Gupta SD, et al. Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer. 2007;120:2545\u201356. 10.1002/ijc.22657", "ArticleIdList": ["10.1002/ijc.22657", "17354234"]}, {"Citation": "Lee JH, Rangappa S, Mohan CD, Basappa, Sethi G, Lin ZX, Rangappa KS, Ahn KS. Brusatol, a Nrf2 inhibitor targets STAT3 signaling cascade in head and neck squamous cell carcinoma. Biomolecules. 2019;9:550. 10.3390/biom9100550", "ArticleIdList": ["10.3390/biom9100550", "PMC6843503", "31575007"]}, {"Citation": "Behera AK, Kumar M, Shanmugam MK, Bhattacharya A, Rao VJ, Bhat A, et al. Functional interplay between YY1 and CARM1 promotes oral carcinogenesis. Oncotarget. 2019;10:3709\u201324. 10.18632/oncotarget.26984", "ArticleIdList": ["10.18632/oncotarget.26984", "PMC6557205", "31217904"]}, {"Citation": "Selvi RB, Swaminathan A, Chatterjee S, Shanmugam MK, Li F, Ramakrishnan GB, et al. Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model. Oncotarget. 2015;6:43806\u201318. 10.18632/oncotarget.6245", "ArticleIdList": ["10.18632/oncotarget.6245", "PMC4791268", "26517526"]}, {"Citation": "Li F, Shanmugam MK, Siveen KS, Wang F, Ong TH, Loo SY, et al. Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers. Oncotarget. 2015;6:5147\u201363. 10.18632/oncotarget.2881", "ArticleIdList": ["10.18632/oncotarget.2881", "PMC4467139", "25762616"]}, {"Citation": "Li F, Shanmugam MK, Chen L, Chatterjee S, Basha J, Kumar AP, et al. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev Res (Phila). 2013;6:843\u201354. 10.1158/1940-6207.CAPR-13-0070", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0070", "23803415"]}, {"Citation": "Thakur KK, Bordoloi D, Prakash J, Monisha J, Roy NK, Kunnumakkara AB. Different chemosensitization approaches for the effective management of HNSCC. In: Kunnumakkara AB, Bordoloi D, Monisha J.editors. Cancer cell chemoresistance and chemosensitization. Singapore: World Scientific; 2018. pp. 399\u2013423."}, {"Citation": "Li C, Zang Y, Sen M, Leeman-Neill RJ, Man DS, Grandis JR, et al. Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death. Mol Cancer Ther. 2009;8:2211\u201320. 10.1158/1535-7163.MCT-09-0327", "ArticleIdList": ["10.1158/1535-7163.MCT-09-0327", "PMC2768047", "19638453"]}, {"Citation": "Singh AK, Roy NK, Anip A, Banik K, Monisha J, Bordoloi D, et al. Different methods to inhibit chemoresistance in hepatocellular carcinoma. In: Kunnumakkara AB, Bordoloi D, Monisha J.editors. Cancer cell chemoresistance and chemosensitization. Singapore: World Scientific; 2018. pp. 373\u201398."}, {"Citation": "Swamy SG, Kameshwar VH, Shubha PB, Looi CY, Shanmugam MK, Arfuso F, et al. Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma. Target Oncol. 2017;12:1\u201310. 10.1007/s11523-016-0452-7", "ArticleIdList": ["10.1007/s11523-016-0452-7", "27510230"]}, {"Citation": "Sethi G, Chatterjee S, Rajendran P, Li F, Shanmugam MK, Wong KF, et al. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Mol Cancer. 2014;13:66. 10.1186/1476-4598-13-66", "ArticleIdList": ["10.1186/1476-4598-13-66", "PMC3998115", "24655440"]}, {"Citation": "Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, et al. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo. J Biol Chem. 2014;289:34296\u2013307. 10.1074/jbc.M114.601104", "ArticleIdList": ["10.1074/jbc.M114.601104", "PMC4256360", "25320076"]}, {"Citation": "Dai X, Ahn KS, Kim C, Siveen KS, Ong TH, Shanmugam MK, et al. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3. Mol Oncol. 2015;9:818\u201333. 10.1016/j.molonc.2014.12.008", "ArticleIdList": ["10.1016/j.molonc.2014.12.008", "PMC5528777", "25624051"]}, {"Citation": "Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, et al. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol. 2012;227:2184\u201395. 10.1002/jcp.22954", "ArticleIdList": ["10.1002/jcp.22954", "21792937"]}, {"Citation": "Rajendran P, Li F, Manu KA, Shanmugam MK, Loo SY, Kumar AP, et al. \u03b3-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent. Br J Pharmacol. 2011;163:283\u201398. 10.1111/j.1476-5381.2010.01187.x", "ArticleIdList": ["10.1111/j.1476-5381.2010.01187.x", "PMC3087132", "21198544"]}, {"Citation": "Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2010;334:285\u201393. 10.1124/jpet.110.165498", "ArticleIdList": ["10.1124/jpet.110.165498", "20378717"]}, {"Citation": "Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, et al. Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood. 2004;103:3175\u201384. 10.1182/blood-2003-06-2151", "ArticleIdList": ["10.1182/blood-2003-06-2151", "15070700"]}, {"Citation": "Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005;70:700\u201313. 10.1016/j.bcp.2005.04.043", "ArticleIdList": ["10.1016/j.bcp.2005.04.043", "16023083"]}, {"Citation": "Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, et al. Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-\u03baB regulated gene products in multiple myeloma xenograft mouse model. Oncotarget. 2014;5:634\u201348. 10.18632/oncotarget.1596", "ArticleIdList": ["10.18632/oncotarget.1596", "PMC3996662", "24504138"]}, {"Citation": "Arora L, Kumar AP, Arfuso F, Chng WJ, Sethi G. The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies. Cancers (Basel). 2018;10:327. 10.3390/cancers10090327", "ArticleIdList": ["10.3390/cancers10090327", "PMC6162647", "30217007"]}, {"Citation": "Samudio I, Konopleva M, Safe S, McQueen T, Andreeff M. Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure. Mol Cancer Ther. 2005;4:1982\u201392. 10.1158/1535-7163.MCT-05-0247", "ArticleIdList": ["10.1158/1535-7163.MCT-05-0247", "16373713"]}, {"Citation": "Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, et al. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 2010;127:257\u201368. 10.1002/ijc.25041", "ArticleIdList": ["10.1002/ijc.25041", "PMC3090706", "19908231"]}, {"Citation": "Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007;67:3853\u201361. 10.1158/0008-5472.CAN-06-4257", "ArticleIdList": ["10.1158/0008-5472.CAN-06-4257", "17440100"]}, {"Citation": "Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491\u20139. 10.1158/1078-0432.CCR-08-0024", "ArticleIdList": ["10.1158/1078-0432.CCR-08-0024", "18628464"]}, {"Citation": "Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, et al. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. Cancer Res. 2010;70:8695\u2013705. 10.1158/0008-5472.CAN-10-2318", "ArticleIdList": ["10.1158/0008-5472.CAN-10-2318", "PMC2970705", "20864511"]}, {"Citation": "Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, et al. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets. Int J Cancer. 2012;131:E292\u2013303. 10.1002/ijc.26442", "ArticleIdList": ["10.1002/ijc.26442", "PMC3288649", "21935918"]}, {"Citation": "Harikumar KB, Kunnumakkara AB, Ochi N, Tong Z, Deorukhkar A, Sung B, et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther. 2010;9:1136\u201346. Erratum in: Mol Cancer Ther. 2010;9:2153. 10.1158/1535-7163.MCT-09-1145", "ArticleIdList": ["10.1158/1535-7163.MCT-09-1145", "PMC2905628", "20442301"]}, {"Citation": "Lee JY, Lee KT, Lee JK, Lee KH, Jang KT, Heo JS, et al. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. Br J Cancer. 2011;104:1027\u201337. 10.1038/bjc.2011.37", "ArticleIdList": ["10.1038/bjc.2011.37", "PMC3065277", "21364590"]}, {"Citation": "Kohyama A, Yokoyama R, Dibwe DF, El-Mekkawy S, Meselhy MR, Awale S, et al. Synthesis of guggulsterone derivatives as potential anti-austerity agents against PANC-1 human pancreatic cancer cells. Bioorg Med Chem Lett. 2020;30:126964. 10.1016/j.bmcl.2020.126964", "ArticleIdList": ["10.1016/j.bmcl.2020.126964", "32057581"]}, {"Citation": "Ahn DW, Seo JK, Lee SH, Hwang JH, Lee JK, Ryu JK, et al. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Pancreas. 2012;41:1048\u201357. 10.1097/MPA.0b013e318249d62e", "ArticleIdList": ["10.1097/MPA.0b013e318249d62e", "22513291"]}, {"Citation": "Zhang J, Sikka S, Siveen KS, Lee JH, Um JY, Kumar AP, et al. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer. Apoptosis. 2017;22:158\u201368. 10.1007/s10495-016-1313-7", "ArticleIdList": ["10.1007/s10495-016-1313-7", "27900636"]}, {"Citation": "Lee JH, Kim C, Baek SH, Ko JH, Lee SG, Yang WM, et al. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer. Oncotarget. 2017;8:17700\u201311. 10.18632/oncotarget.10775", "ArticleIdList": ["10.18632/oncotarget.10775", "PMC5392279", "27458171"]}, {"Citation": "Zhang J, Ahn KS, Kim C, Shanmugam MK, Siveen KS, Arfuso F, et al. Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model. Antioxid Redox Signal. 2016;24:575\u201389. 10.1089/ars.2015.6418", "ArticleIdList": ["10.1089/ars.2015.6418", "26649526"]}, {"Citation": "Kim C, Cho SK, Kapoor S, Kumar A, Vali S, Abbasi T, et al. \u03b2-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase. Mol Carcinog. 2014;53:793\u2013806. 10.1002/mc.22035", "ArticleIdList": ["10.1002/mc.22035", "23765383"]}, {"Citation": "Muralimanoharan SB, Kunnumakkara AB, Shylesh B, Kulkarni KH, Haiyan X, Ming H, et al. Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells. Prostate. 2009;69:494\u2013504. 10.1002/pros.20899", "ArticleIdList": ["10.1002/pros.20899", "PMC2674392", "19107816"]}, {"Citation": "Heymach JV, Shackleford TJ, Tran HT, Yoo SY, Do KA, Wergin M, et al. Effect of low-fat diets on plasma levels of NF-\u03baB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res (Phila). 2011;4:1590\u20138. 10.1158/1940-6207.CAPR-10-0136", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0136", "PMC3438697", "21764858"]}, {"Citation": "Xiao D, Singh SV. z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo. Mol Cancer Ther. 2008;7:171\u201380. 10.1158/1535-7163.MCT-07-0491", "ArticleIdList": ["10.1158/1535-7163.MCT-07-0491", "18202020"]}, {"Citation": "Koo JH, Rhee KS, Koh HW, Jang HY, Park BH, Park JW. Guggulsterone inhibits melanogenesis in B16 murine melanoma cells by downregulating tyrosinase expression. Int J Mol Med. 2012;30:974\u20138. 10.3892/ijmm.2012.1057", "ArticleIdList": ["10.3892/ijmm.2012.1057", "22797252"]}, {"Citation": "Verma N, Singh SK, Gupta RC. Simultaneous determination of the stereoisomers of guggulsterone in serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1998;708:243\u20138. 10.1016/s0378-4347(97)00626-9", "ArticleIdList": ["10.1016/s0378-4347(97)00626-9", "9653969"]}, {"Citation": "Verma N, Singh SK, Gupta RC. Pharmacokinetics of guggulsterone after intravenous and oral administration in rats. Pharm Pharmacol Comm. 1999;5:349\u201354. 10.1211/146080899128734956", "ArticleIdList": ["10.1211/146080899128734956"]}, {"Citation": "Bhatta RS, Kumar D, Chhonker YS, Jain GK. Simultaneous estimation of E- and Z-isomers of guggulsterone in rabbit plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic study. Biomed Chromatogr. 2011;25:1054\u201360. 10.1002/bmc.1574", "ArticleIdList": ["10.1002/bmc.1574", "21268049"]}, {"Citation": "Chhonker YS, Chandasana H, Mukkavilli R, Prasad YD, Laxman TS, Vangala S, et al. Assessment of in vitro metabolic stability, plasma protein binding, and pharmacokinetics of E- and Z-guggulsterone in rat. Drug Test Anal. 2016;8:966\u201375. 10.1002/dta.1885", "ArticleIdList": ["10.1002/dta.1885", "26608935"]}, {"Citation": "Yang D, Yang J, Shi D, Xiao D, Chen YT, Black C, et al. Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump. J Lipid Res. 2012;53:529\u201339. 10.1194/jlr.M014688", "ArticleIdList": ["10.1194/jlr.M014688", "PMC3276476", "22246918"]}, {"Citation": "Chhonker YS, Chandasana H, Bala V, Mukkavilli R, Kumar D, Vangala S, et al. In-vitro metabolism, CYP profiling and metabolite identification of E- and Z-guggulsterone, a potent hypolipidmic agent. J Pharm Biomed Anal. 2018;160:202\u201311. 10.1016/j.jpba.2018.06.047", "ArticleIdList": ["10.1016/j.jpba.2018.06.047", "30099292"]}, {"Citation": "Balhara A, Ladumor M, Singh DK, Praneetha P, Preethi J, Pokharkar S, et al. In vitro evaluation of reactive nature of E- and Z-guggulsterones and their metabolites in human liver microsomes using UHPLC-Orbitrap mass spectrometer. J Pharm Biomed Anal. 2020;186:113275. 10.1016/j.jpba.2020.113275", "ArticleIdList": ["10.1016/j.jpba.2020.113275", "32247160"]}, {"Citation": "Singh AK, Roy NK, Bordoloi D, Padmavathi G, Banik K, Khwairakpam AD, et al. Orai-1 and Orai-2 regulate oral cancer cell migration and colonisation by suppressing Akt/mTOR/NF-\u03baB signalling. Life Sci. 2020;261:118372. 10.1016/j.lfs.2020.118372", "ArticleIdList": ["10.1016/j.lfs.2020.118372", "32882268"]}, {"Citation": "Roy NK, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar NS, Singh AK, et al. Isoform-specific role of akt in oral squamous cell carcinoma. Biomolecules. 2019;9:253. 10.3390/biom9070253", "ArticleIdList": ["10.3390/biom9070253", "PMC6681224", "31252679"]}, {"Citation": "Parama D, Boruah M, Kumari Y, Rana V, Banik K, Harsha C, et al. Diosgenin, a steroidal saponin, and its analogues: effective therapies against different chronic diseases. Life Sci. 2020:118182. 10.1016/j.lfs.2020.118182", "ArticleIdList": ["10.1016/j.lfs.2020.118182", "32781063"]}, {"Citation": "Bordoloi D, Banik K, Padmavathi G, Vikkurthi R, Harsha C, Roy NK, et al. TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of Akt/mTOR/NF-\u03baBsignaling cascade. Biomolecules. 2019;9:836. 10.3390/biom9120836", "ArticleIdList": ["10.3390/biom9120836", "PMC6995575", "31817720"]}, {"Citation": "Monisha J, Roy NK, Padmavathi G, Banik K, Bordoloi D, Khwairakpam AD, et al. NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance. Cancers (Basel). 2018;10:228. 10.3390/cancers10070228", "ArticleIdList": ["10.3390/cancers10070228", "PMC6071146", "29996471"]}, {"Citation": "Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2006;1091:151\u201369. 10.1196/annals.1378.063", "ArticleIdList": ["10.1196/annals.1378.063", "17341611"]}, {"Citation": "Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol. 2008;75:787\u2013809. 10.1016/j.bcp.2007.08.016", "ArticleIdList": ["10.1016/j.bcp.2007.08.016", "17900536"]}, {"Citation": "Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol. 2008;76:1590\u2013611. 10.1016/j.bcp.2008.08.008", "ArticleIdList": ["10.1016/j.bcp.2008.08.008", "18775680"]}, {"Citation": "Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an \u201cold-age\u201d disease with an \u201cage-old\u201d solution. Cancer Lett. 2008;267:133\u201364. 10.1016/j.canlet.2008.03.025", "ArticleIdList": ["10.1016/j.canlet.2008.03.025", "18462866"]}, {"Citation": "Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174:1325\u201348. 10.1111/bph.13621", "ArticleIdList": ["10.1111/bph.13621", "PMC5429333", "27638428"]}, {"Citation": "Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res. 2008;14:2128\u201336. 10.1158/1078-0432.CCR-07-4722", "ArticleIdList": ["10.1158/1078-0432.CCR-07-4722", "18381954"]}, {"Citation": "Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, et al. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res. 2007;13:3024\u201332. 10.1158/1078-0432.CCR-06-2575", "ArticleIdList": ["10.1158/1078-0432.CCR-06-2575", "17505005"]}, {"Citation": "Pandey MK, Sandur SK, Sung B, Sethi G, Kunnumakkara AB, Aggarwal BB. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. J Biol Chem. 2007;282:17340\u201350. 10.1074/jbc.M700890200", "ArticleIdList": ["10.1074/jbc.M700890200", "17439942"]}, {"Citation": "Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer. 2009;125:2187\u201397. 10.1002/ijc.24593", "ArticleIdList": ["10.1002/ijc.24593", "19623659"]}, {"Citation": "Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008;68:5370\u20139. 10.1158/0008-5472.CAN-08-0511", "ArticleIdList": ["10.1158/0008-5472.CAN-08-0511", "18593939"]}, {"Citation": "Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol Cancer Ther. 2009;8:959\u201370. 10.1158/1535-7163.MCT-08-0905", "ArticleIdList": ["10.1158/1535-7163.MCT-08-0905", "PMC2694943", "19372569"]}, {"Citation": "Harikumar KB, Kunnumakkara AB, Ahn KS, Anand P, Krishnan S, Guha S, et al. Modification of the cysteine residues in IkappaB alpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood. 2009, 113:2003\u201313. 10.1182/blood-2008-04-151944", "ArticleIdList": ["10.1182/blood-2008-04-151944", "PMC2947354", "18952893"]}, {"Citation": "Nair AS, Shishodia S, Ahn KS, Kunnumakkara AB, Sethi G, Aggarwal BB. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol. 2006;177:5612\u201322. 10.4049/jimmunol.177.8.5612", "ArticleIdList": ["10.4049/jimmunol.177.8.5612", "17015749"]}, {"Citation": "Buhrmann C, Shayan P, Banik K, Kunnumakkara AB, Kubatka P, Koklesova L, et al. Targeting NF-\u03baBsignaling by calebin A, a compound of turmeric, in multicellular tumor microenvironment: potential role of apoptosis induction in CRC cells. Biomedicines. 2020;8:236. 10.3390/biomedicines8080236", "ArticleIdList": ["10.3390/biomedicines8080236", "PMC7460490", "32708030"]}]}], "History": [{"Year": "2020", "Month": "8", "Day": "8"}, {"Year": "2020", "Month": "9", "Day": "14"}, {"Year": "2022", "Month": "9", "Day": "1", "Hour": "2", "Minute": "30"}, {"Year": "2020", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36046484", "PMC9400725", "10.37349/etat.2020.00019", "etat-01-100219"]}}]}